On Apr. 21, 2025, the National Institutes of Health (NIH) reported that overall death rates from cancer declined steadily among…
On Jun. 26. 2024, the World Health Organization reported that new data show that nearly one third (31%)…
On Dec. 24, 2022, the U.S. Food and Drug Administration (FDA) approved updated labeling for Genentech’s capecitabine tablets…
On Jan. 9, 2017, the Canada Foundation for Innovation (CFI) awarded $6 million for Canada’s national metabolomics laboratory,…
On Dec. 1, 2013, researchers at the Princess Margaret Hospital in Toronto, led by Dr. John Dick, announced…
On Jan. 9, 2004, the Food and Drug Administration (FDA) announced the approval of Sanofi’s Eloxatin (oxaliplatin) injection…
On Feb. 29. 2000, President Clinton officially dedicated March as National Colorectal Cancer Awareness Month. Since then, it…
On April 30, 1998, the U.S. Food and Drug Administration (FDA) approved the Genentech’s drug Xeloda (capecitabine) for…
On Dec. 2, 1993, Dana-Farber scientists identified the gene that causes an inherited form of colon cancer, which…
On May 7, 1993, the first gene associated with hereditary nonpolyposis colon cancer (HNPCC) was cloned (hMSH2). People…
In 1991, The Northwestern University Cancer Center was dedicated through an endowment gift from Ann and Robert H….
In 1970, flexible sigmoidoscopy and colonoscopy were introduced to locate and remove precancerous growths in the colon. Clinical…